Breath of Life International Pharma Ltd   Report issue

For profit Phase 1 Phase 2
Founded: Revadim Israel (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2018
NCT04145310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Breath of Life International Pharma Ltd

Active Ingredients

Drugs in Phase 2 Trials (2)

bol-dp-o-05 (1 trial)

cannabis (2 trials)

Drugs in Phase 1 Trials (1)

bol-pk-st-02 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetic Neuropathies (Phase 2)

Low Back Pain (Phase 2)

Sciatica (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3